Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Detalles Bibliográficos
Autores principales: Tajiri, Hitoshi, Motoya, Satoshi, Kinjo, Fukunori, Maemoto, Atsuo, Matsumoto, Takayuki, Sato, Noriko, Yamada, Hiroshi, Nagano, Mieko, Susuta, Yutaka, Ozaki, Kunihiko, Kondo, Kazuoki, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017882/
https://www.ncbi.nlm.nih.gov/pubmed/35439252
http://dx.doi.org/10.1371/journal.pone.0261932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017882/
https://www.ncbi.nlm.nih.gov/pubmed/35439252
http://dx.doi.org/10.1371/journal.pone.0261932

Ejemplares similares